Pharmacy Logs and Worksheets

Similar documents
The REDOXS Study. REducing Deaths due to OXidative Stress. A randomized trial of glutamine and antioxidant supplementation in critically ill patients

The REDOXS Study. REducing Deaths due to OXidative Stress. A randomized trial of glutamine and antioxidant supplementation in critically ill patients

HOW TO MANAGE AND ADMINISTER THE TRIAL TREATMENT

REducing Deaths from OXidative Stress

Pharmacy Manual. Cambridge University Hospitals NHS Foundation Trust & University of Cambridge

Ascribe Rx Online Resource Center User Guide

Ratios and Proportions. Calculations for Pharmacy Technicians 9/21/2017. Presented by: Antonia Kraljevic PGY2 Pharmacy Practice Resident

November 9, Clarification Memo 1 Version 3.0 HVTN 704/HPTN 085

Index No: MMG11/1. Version: 1. Date ratified: 12 th November 2013

EasyComp. The TPN Compatibility Software. Clinical Nutrition

CYCLE Vanguard: Flow Sheet for Protocol Schedule of Forms + Procedures. Binder Title and Cover Pages. Required Materials Study Schema RC flowsheet

Tech Lectures For the Pharmacy Technician

Guidance on Bulk Prescribing for Care Home Patients

Research Compliance and Quality Assurance Program (RCQA): Audit Checklist Subject Specific

ARCADIA Study Coordinator Training Investigator Meeting

Pharmacy Plan Guidance

Prevention of Transcription Errors with Pediatric TPN Orders Using a Web Interface

Nonparenteral medications

Review calculation procedures for the following:

This document is to help guide the use of the provided GRH IV Iron Sucrose package. The documents included in the IV Iron Sucrose Package are:

DRUG ORDERING & DISPENSING:

Intravenous Immunoglobulin (IVIg) prescribing guidance

EVERY SHOT COUNTS C O R O N A D O R O O M A U G U S T 1 6,

TOTAL PARENTERAL NUTRITION

MOST Clinical Performing Site Study Drug Procedures

Chapter 12.0: Test Article Preparation, Accountability, (Pharmacy Manual) and Administration

Guidance on Bulk Prescribing for Care Home Residents

Documenting Patient Immunization. New Brunswick 2018/19

11.1 Supplemental Antioxidant Nutrients: Combined Vitamins and Trace Elements April 2013

Refilling a Prescription with No Refills Remaining

APIDRA (insulin glulisine) injection vial APIDRA SOLOSTAR (insulin glulisine) subcutaneous solution pen-injector

Documenting Patient Immunization. Ontario 2018/19

PAGE 1 of 6. Summative Assessment - Dietary Analysis Report Data Worksheets

Medicines Optimisation Team Standard Operating Procedure Insulin Quantities Audit

1. Intrathecal must never be abbreviated to IT on a prescription form True / False

Package leaflet: Information for the user. Aminoven 5% Solution for infusion Aminoven 10% Solution for infusion Aminoven 15% Solution for infusion

Drug Prior Authorization Form Opdivo (nivolumab)

CHAPTER 6 EXAMINATION SCHEDULE 6.1 OVERVIEW OF SCHEDULE AND DESCRIPTION OF PARTICIPANT VISITS

SECTION 4: RECRUIT PARTICIPANTS

Newfoundland and Labrador Pharmacy Board Standards of Practice

Standard Operating Procedures Clinical and Translational Research Center

HIV MANAGEMENT PROGRAMME APPLICATION FORM

PACKAGE LEAFLET: INFORMATION FOR THE USER

Immunization Toolkit for Immunization Providers

Version: Date. Version 2: 02-September Feb-2016

ProScript User Guide. Pharmacy Access Medicines Manager

Investigational Product Procedures Manual

INFORMATION FOR FILLING OUT APPLICATION FORM FOR AN EXEMPTION TO USE A CONTROLLED SUBSTANCE FOR SCIENTIFIC PURPOSES (a Health Canada document)

Urine Dipstick Medical Mobile Unit: Patient Test Procedure

Health Services. Procedure Manual

Common Infusions for Neonatal Use

Section: Claims Payment - Cognitive Services (PAS Policy Administered by Drug Plan and Extended Benefits Branch)

Eligibility Form. 1. Patient Profile. (This form must be completed before the first dose is dispensed.) Request prior approval for enrolment

Homely Remedies Guidance for Care Homes

ISMP guidelines that support intravenous drug delivery system safety

Parenteral Nutrition Recommendations for Pediatric Patients

Controlled Drug Process. Khoa Vo Masters candidate University of Canterbury

Cumulative Math Practice Worksheet

PHARMACY DOSING AND ORDERING GUIDE

Navigating Alliance Protocols

IMPAACT MOCHA More Options for Children and Adolescents

EHS Integrator Controlled Substance Waste Pickup Request Help Guide

NEW ZEALAND DATA SHEET

Paediatric Prescribing Pocket Guide September 2014 (Version 1)

Catalogue. Medication Safety Labels CONTENTS 1. For the Safe Management of Medication Version 2. Anaesthetic Syringe Labels

SAVAYSA (edoxaban tosylate) oral tablet

Therapy Activation Date: Review Date:

Care homes - Homely remedies

HOSA MEDICAL MATH CONVERSION CHART METRIC SYSTEM

Education for self administration of intravenous therapy HOME IV THERAPY. 30 minute - Baxter Pump Tobramycin

Introduction. Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients)

Cox College Springfield, MO. Dosage Calculation Competency Level II Practice Sheet STUDENT NAME: DATE: STUDENT I.D. #: ADVISOR:

Nancy Knickerbocker State Flu Vaccine Coordinator County of San Diego Immunization Program

Freka Balloon Gastrostomy Feeding. CARE GUIDELINES For Patients & Carers

LOKELMA (sodium zirconium cyclosilicate) oral suspension

Diabetes Medical Management Plan/Individualized Healthcare Plan. Part A: Contact Information must be completed by the parent/guardian.

1. When are dispensers able to provide publicly funded naloxone emergency kits for Ontarians?

*Note - If associate is unsuccessful in their attempt to complete the dosage calculation test

Good Practice Guidance on Homely Remedy Policy For Adult Service Users in Care Homes

Research & Development. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff

3.0 POSITION ON PRE-LOADING SYRINGES WITH VACCINE

Before you use NovoThirteen. When NovoThirteen should not be used

TEST ARTICLE TEST PERFORMED PERFORMING LABORATORY SAMPLES SUBMITTED RESULT

C H C S TAT E I N F L U E N Z A VA C C I N E R E Q U I R E M E N T S T R A I N I N G F O R C O M M U N I T Y P R O V I D E R S

LEVEMIR (insulin detemir) subcutaneous solution LEVEMIR FLEXTOUCH (insulin detemir) subcutaneous solution pen-injector

Creating EVENTS in TPN s Partner Portal Step 1: Scroll down to the footer of the home page and click on PARTNER LOGIN:

CYSTARAN (cysteamine hydrochloride) ophthalmic solution

STATE FUNDED INFLUENZA FINAL OUTCOME REPORT AND SDIR DOCUMENTATION

Vaccine Starter Kit Program FAQs

Medicare & Dual Options. 1. Every page of the EMR document must include: a. Member Name b. Patient Identifiers (i.e. Date of Birth) c.

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Technology Appraisals. Patient Access Scheme Submission Template

BLOOD GLUCOSE METER TEST STRIP STEP THERAPY CRITERIA

Home Care Services HomeMed MedEQUIP Michigan Visiting Care Michigan Visiting Nurses Wheelchair Seating Service PROCEDURE

MedsCheck Reviews. Ontario

Department of Pathology and Laboratory Medicine

EUROPEAN MEDICINES AGENCY DECISION. of 7 September 2009

MAGDALENE CATHOLIC HIGH SCHOOL Because I have seen the Lord. Anaphylaxis Policy

Transcription:

Pharmacy Logs and Worksheets 1

Monthly Site Inventory Log Month Year To be filled out by Site Pharmacy monthly and faxed to Clinical Evaluation Research Unit (CERU). Name of Site: Pharmacist: Phone: Product Supplier Minimum Supply needed Actual supplies Amount needed Dipeptiven (100 ml bottles) Fresenius 80 bottles* bottles bottles (10 bottles per carton) Kabi (FK) EN REDOXS formula (500 mls bottles) (12 bottles per carton) AOX + GLN FK 36 bottles bottles bottles AOX FK 36 bottles bottles bottles GLN FK 36 bottles bottles bottles Placebo FK 36 bottles bottles bottles Selenase(10 ml vials) Biosyn 40 vials vials vials * based on 4 patients, each needing 2 bottles per day for 10 days based on 4 patients, each needing 1 bottle per day for 9 days based on 4 patients, each needing approximately 1 vials/day per day for 10 days Checked by CERU Project Assistant Signature of person completing log: Fax completed form to: CERU (613) 548-2428 Date Attention: REDOXS Study (613) 549-6666 ext 6686 or 4847 2

Monthly Site Temperature Log Month Year To be filled out by Site Pharmacy daily and faxed to Clinical Evaluation Research Unit (CERU) monthly. Name of Site: Pharmacist: Phone: Date Temperature Low Température Bas Temperature Current Température Présent Temperature High Température Haut Date 01 16 02 17 03 18 04 19 05 20 06 21 07 22 08 23 09 24 10 25 11 26 12 27 13 28 14 29 15 30 31 Temperature Low Température Bas Temperature Current Température Présent Temperature High Température Haut Signature of person submitting log: Fax completed form to: CERU (613) 548-2428 Attention: REDOXS Study (613) 549-6666 ext 6686 or 4847 3

Enteral Product Label Log Page of Pharmacist to place removable labels here daily (use one page is for 3 days) Patient ID #: Patient Initials: Enrollment#: Treatment Group (circle one): AOX GLN AOX+ GLN Placebo Date dd/mm/yyyy Date dd/mm/yyyy Date dd/mm/yyyy 4

Enteral Study Supplement Dispensing Log Page of To be filled out by Pharmacist Patient ID # Patient Initials: Enrollment #: Dose: 480 mls/day Infusion Rate: 20 mls/hour Treatment Group (circle one): AOX GLN AOX+ GLN Placebo Prepared by Checked Checked by Date dd/mm/yyyy Lot # Expiry by study monitor 5

Parenteral Study Supplement Dispensing Log Page of To be filled out by Pharmacist Patient ID #: Patient Initials: Height: cms Enrollment #: Treatment Group: (circle one): AOX GLN AOX+ GLN Placebo Infusion Rate of Final Product: 10 ml/hr (or > if tall) Dipeptiven Selenium Saline/D5W Signatures Date dose (mls) Lot # & expiry dose (mls) Lot # & expiry dose (mls) Lot # & expiry Manufacturer Prepared by Checked by Audited by: 6

Nutrient Accountability Log Enteral AOX Page of Site #: To be filled out by Pharmacist Date Quantity received or destroyed Lot # Expiry date Quantity dispensed Patient enrollment # Balance of Product Signature 7

Nutrient Accountability Log Enteral GLN Page of Site #: To be filled out by Pharmacist Date Quantity received or destroyed Lot # Expiry date Quantity dispensed Patient enrollment # Balance of Product Signature Audited by: 8

Nutrient Accountability Log Enteral AOX+GLN Page of Site #: To be filled out by Pharmacist Date Quantity received or destroyed Lot # Expiry date Quantity dispensed Patient enrollment # Balance of Product Signature Audited by: 9

Nutrient Accountability Log Enteral Placebo Page of Site #: To be filled out by Pharmacist Date Quantity received or destroyed Lot # Expiry date Quantity dispensed Patient enrollment # Balance of Product Signature Audited by: 10

Nutrient Accountability Log Dipeptiven Page of Site #: To be filled out by Pharmacist Date Quantity received or destroyed Lot # Expiry date Quantity dispensed Patient enrollment # Balance of Product Signature Audited by: 11

Nutrient Accountability Log Selenase Page of Site #: To be filled out by Pharmacist Date Quantity received or destroyed Lot # Expiry date Quantity dispensed Patient enrollment # Balance of Product Signature Audited by: 12

Appendices Appendix A: Site Investigator Delegation of Authority Log Appendix B: Pharmacy Training/Delegation of Authority Log Appendix C: Pharmacy Web Access Signature Log Appendix D: Randomization Process on Web Appendix E: Enteral Study Supplement Label Template Appendix F: Parenteral Study Supplement Worksheets Appendix G: Parenteral Study Supplement Label Template Appendix H: Height and Dose of Dipeptiven 13

14

15

Pharmacy Web access Signature Log INSTITUTION: SITE NUMBER: INVESTIGATOR: Please complete the Electronic Data Capture (EDC) System Access Signature Sheet for each Pharmacist/technician at your site who will be checking the randomization or dispensing/checking study supplements. A signature and email address is required to create user accounts for the web based system for the REDOXS Study. NAME TITLE SIGNATURE EMAIL DATE NOTE: By completing the information in the table above, the individual confirms they have been delegated the responsibility of checking the randomization and dispensing/verifying study supplements for the REDOXS Study. Reference: ICH GCP 5.5.3 16

Appendix D Randomization Process on Web Screen New Subject Only Subjects Who Meet Inclusion Screening Form Inclusion/Exclusion Meets an Exclusion Ends No Exclusion Eligible for Study Pre Randomization Form Eligibility Must Be Confirmed By MD Do you want to obtain consent? Ends Explain why No Pharmacist Receives call from Study Coordinator Pharmacist Logs onto Web Yes Consent Obtained Subject s Height in cm. CLICK here to Randomize Patient button Pharmacist Receives Treatment Assignment Subject s Initials Date of Birth Height Subject is now Randomized Enrollment Number Is Contact your Site Pharmacy and enter date and time of contact. Provide Height/Subject Initials/ DOB/Enrollment Number After Randomization Study Coordinator to Complete Baseline Form & APACHE Score and other Electronic CRFs 17

Appendix E Enteral Study Supplement Study: REDOXS Enteral Component For Clinical trial Use Only Enrollment #: Patient ID/CR#: Patient Name: Physician: Directions: Infuse at 20 ml/hr Storage: keep between 15-25 C Expiry: use within 24 hours Date: 18

Appendix F Parenteral Study Supplement Worksheets Use the appropriate worksheet according to the group the patient has been randomized to. These worksheets will assist in calculating the volumes of the parenteral study supplements and normal saline or D5W needed. Worksheet for Antioxidants (AOX) Worksheet for Glutamine (GLN) Worksheet for (Antioxidant + Glutamine) AOX + GLN Worksheet for Placebo 19

Parenteral Supplements Worksheet Patient CR# / ID# Patient Initials Enrolment # Antioxidants (AOX) Patient will receive Selenium (Antioxidants) and normal saline (or if hypernatremic D5W) Begin with a bag containing exactly 250 ml of normal saline (i.e. account for overfill): 1. Volume of Dipeptiven to be added = _0_mL 2. Volume of Selenium to be added = _10 ml_ 3. Total Volume to be removed from 250 ml normal saline bag before adding study supplements: (# 1) + (# 2) = _10_ ml volume of dipeptiven volume of selenium 4. Add (#1) + (#2) + normal saline =_250 ml_ 5. Record the volumes of Selenium and Normal Saline on the Parenteral Study Supplement Log for this patient daily. 6. Generate a label and attach to bag. Dipeptiven not required for this treatment arm Note: Height of the patient not required to calculate the AOX dose version: 3-Jul-09 (EU) Replaces version: 9-Sept-07 (EU)

Parenteral Supplements Worksheet (Patients > 196 cm tall) Patient CR# / ID# Patient Initials Enrolment # Antioxidants (AOX) Patient will receive Selenium (Antioxidants) and normal saline (or if hypernatremic D5W) Dosing: 1. Dosage of Selenium = 500mcg/day = 10mL/day regardless of height 2. Rate of infusion determined from chart below. 3. Dose will be diluted in a NS bag to a final volume indicated in the chart below. 4. You must account for overfill in the normal saline bags as per table below. Beginning with a bag of exactly 250 ml of normal saline: Go to height chart (see below). Record: 1. Patient height = cm 2. Final total volume of the bag (from chart below) = ml 3. Rate to be infused (from chart below) = ml/hr 4. Volume of Selenium to be added = _10 ml_ Height Final Total Volume of Bag Rate to be Infused Volume of Selenium to be Added Amount of Normal Saline To be removed 196 cm 250 ml 10.4 ml/hr 10 ml 10.0 ml 198 cm 255 ml 10.6 ml/hr 10 ml 15.0 ml To be added 201cm 263 ml 11.0 ml/hr 10 ml 3.0 ml 203 cm 268 ml 11.2 ml/hr 10 ml 8.0 ml 206 cm 275 ml 11.5 ml/hr 10 ml 15.0 ml 208 cm 280 ml 11.7 ml/hr 10 ml 20.0 ml 211 cm 288 ml 12.0 ml/hr 10 ml 28.0 ml 213 cm 293 ml 12.2 ml/hr 10 ml 33.0 ml 5. Volume of NS to be removed or added to bag = ml 6. Add Selenium (#4), as per chart, to normal saline bag. Mix. 7. Record the volumes of Selenium and Normal Saline on the Parenteral Study Supplement Log for this patient daily. 8. Generate a label and attach to bag. Version: 3-Jul-09 (EU) Replaces version: 6-Dec-07 (EU)

Parenteral Supplements Worksheet Patient CR# / ID# Patient Initials Enrolment # Glutamine (GLN) Patient will receive Dipeptiven (Glutamine) and normal saline (or if hypernatremic DSW) Begin with a bag containing exactly 250 ml of normal saline (i.e. account for overfill): 1. Patient s height = cm 2. Normal Body Weight = (#1) 100 cm = kg 3. Volume of Dipeptiven to be added = (#2) x 2.5 ml = ml 4. Volume of Selenium to be added = 0 ml_ 5. Total Volume to be removed from 250 ml normal saline bag before adding study supplements: (# 3) + (# 4)_ = ml volume of dipeptiven volume of selenium 7. Add (#3) + (#4) + normal saline =_250 ml_ 8. Record the volumes of Dipeptiven and Normal Saline on the Parenteral Study Supplement Log for this patient daily. 9. Generate a label and attach to bag. Dipeptiven 2.5 ml/kg/day =Glutamine 0.35 g/kg/day = L-alanyl-L-glutamine 0.5 g/kg/day Selenium not required for this treatment arm version: 3-Jul-09 (EU) Replaces version: 9-Sept-07 (EU)

Parenteral Supplements Worksheet (Patients > 196 cm tall) Patient CR# / ID# Patient Initials Enrolment # Glutamine (GLN) Patient will receive Dipeptiven (Glutamine) and normal saline (or if hypernatremic D5W) Dosing: 1. Dosage of Glutamine = 0.35g/kg/day = L-alanyl-L-glutamine 0.5g/kg/day= Dipeptivan 2.5mL/kg/day 2. Dosing will be based on patient s Normal Body Weight using Broca Formula as follows: Normal Weight (kg)= Patient s Height (cm) - 100 3. Dose will be diluted in a NS bag to a final volume indicated in the chart below. 4. Rate of infusion determined from chart below. 5. You must account for overfill in the normal saline bags as per table below. Beginning with a bag of exactly 250 ml of normal saline: Go to height chart (see below). Record: 1. Patient height = cm 2. Final total volume of the bag (from chart below) = ml 3. Rate to be infused (from chart below) = ml/hr 4. Volume of Glutamine (Dipeptiven ) to be added = ml Height Final Total Volume of Bag Rate to be Infused Volume of Glutamine to be Added Amount of Normal Saline to be removed 196 cm 253 ml 10.5 ml/hr 240 ml 237 ml 198 cm 258 ml 10.8 ml/hr 245 ml 237 ml 201cm 266 ml 11.1 ml/hr 253 ml 237 ml 203 cm 271 ml 11.3 ml/hr 258 ml 237 ml 206 cm 278 ml 11.6 ml/hr 265 ml 237 ml 208 cm 283 ml 11.8 ml/hr 270 ml 237 ml 211 cm 291 ml 12.1/mL/hr 278 ml 237 ml 213 cm 296 ml 12.3 ml/hr 283 ml 237 ml 5. Volume of NS to be removed from bag = ml 6. Add Dipeptiven (#4), as per chart, to normal saline bag. Mix. 7. Expiry dating = 96 hours at room temperature. 8. Generate a label and attach to bag. Version: 3-Jul-09 (EU) Replaces version: 6-Dec-07 (EU)

Parenteral Supplements Worksheet Patient CR# / ID# Patient Initials Enrolment # Antioxidants + Glutamine (AOX+GLN) Patient will receive Selenium (AOX), Dipeptiven (GLN) and normal saline (or if hypernatremic DSW) Begin with a bag containing exactly 250 ml of normal saline (i.e. account for overfill): 1. Patient s height = cm 2. Normal Body Weight = (#1) 100 cm = kg 3. Volume of Dipeptiven to be added = (#2) x 2.5 ml = ml 4. Volume of Selenium to be added = 10 ml_ 5. Total Volume to be removed from 250 ml normal saline bag before adding study supplements: (#3) + (#4) = ml volume of dipeptiven volume of selenium 6. Add (#3) + (#4) + normal saline =_250 ml_ 7. Record the volumes of Dipeptiven, Selenium and Normal Saline on the Parenteral Study Supplement Log for this patient daily. 8. Generate a label and attach to bag. Dipeptiven 2.5 ml/kg/day =Glutamine 0.35 g/kg/day = L-alanyl-L-glutamine 0.5 g/kg/day version: 3-Jul-09 (EU) Replaces version: 9-Sept-07 (EU)

Parenteral Supplements Worksheet (Patients > 196 cm tall) Patient CR# / ID# Patient Initials Enrolment # 9. Record the volumes of Dipeptiven and Normal Saline on the Parenteral Study Supplement Log for this patient daily. Antioxidants + Glutamine (AOX+GLN) Patient will receive Selenium (AOX), Dipeptiven (GLN) and normal saline (or if hypernatremic D5W) Dosing: 1. Dosage of Selenium = 500mcg/day = 10mL/day regardless of height; 2. Dosage of Glutamine 0.35g/kg/day = L-alanyl-L-glutamine 0.5g/kg/day= Dipeptivan 2.5mL/kg/day 3. Dosing will be based on patient s Normal Body Weight using Broca Formula as follows: Normal Weight (kg) = Patient s Height(cm) - 100 4. Dose will be diluted in a NS bag to a final volume indicated in the chart below. 5. Rate of infusion determined from chart below. ( rate may be increased up to 2x the amount on day 1 for hours missed to conform to standard dosing times) 6. You must account for overfill in the normal saline bags as per table below. Beginning with a bag of exactly 250 ml of normal saline: Go to height chart (see below). Record: 1. Patient height = cm 2. Final total volume of the bag (from chart below) = ml 3. Rate to be infused (from chart below) = ml/hr 4. Volume of Selenium to be added = _10.0 ml_ 5. Volume of Glutamine (Dipeptiven ) to be added = ml Height Final Total Volume of Bag Rate to be Infused Volume of Selenium to be Added Volume of Glutamine to be Added 196 cm 250 ml 10.4 ml/hr 10 ml 240 ml 198 cm 255 ml 10.6 ml/hr 10 ml 245 ml 201cm 263 ml 11.0 ml/hr 10 ml 253 ml 203 cm 268 ml 11.2 ml/hr 10 ml 258 ml 206 cm 275 ml 11.5 ml/hr 10 ml 265 ml 208 cm 280 ml 11.7 ml/hr 10 ml 270 ml 211 cm 288 ml 12.0 ml/hr 10 ml 278 ml 213 cm 293 ml 12.2 ml/hr 10 ml 283 ml 6. Begin with an empty sterile bag, draw up: Selenium (#4) and Glutamine (#5). Add to the bag and mix. 7. Expiry dating = 96 hours at room temperature. 8. Generate a label and attach to bag. Version: 3-Jul-09 (EU) Replaces version: 6-Dec-07 (EU)

Parenteral Supplements Worksheet Patient CR# / ID# Patient Initials Enrolment # Placebo Patient will only receive normal saline (or if hypernatremic D5W) Begin with a bag containing exactly 250 ml of normal saline (i.e. account for overfill): 1. Volume of Dipeptiven to be added = _0_mL 2. Volume of Selenium to be added = 0 ml_ 3. No mixing needed. The patient will receive a 250 ml bag of normal saline. 4. Record the volume of Normal Saline (=250 ml) on the Parenteral Study Supplement Log, for this patient daily. 5. Generate a label and attach to bag. Dipeptiven and Selenium not required for this treatment arm. version: 3-Jul-09 (EU) Replaces version: 9-Sept-07 (EU)

Parenteral Supplements Worksheet (Patients > 196 cm tall) Patient CR# / ID# Patient Initials Enrolment # 9. Record the volumes of Selenium and Dipeptiven on the Parenteral Study Supplement Log for this patient daily. * May want to start with empty bag. Placebo Patient will only receive normal saline (or if hypernatremic D5W) Dosing: 1. Dose will consist of a 250mL NS bag with added NS to a final volume as indicated in chart below. 2. Rate of infusion determined from chart below Beginning with a bag of exactly 250 ml of normal saline: Go to height chart (see below). Record: 1. Patient height = cm 2. Final total volume of the bag (from chart below) = ml 3. Rate to be infused (from chart below) = ml/hr 4. Volume of normal saline to be added = ml Height Final total volume of bag Rate to be infused Amount of normal saline to be added 196 cm 250 ml 10.4 ml/hr 198 cm 255 ml 10.6 ml/hr 5 ml 201 cm 263 ml 11.0 ml/hr 13 ml 203 cm 268 ml 11.2 ml/hr 18 ml 206 cm 275 ml 11.5 ml/hr 25 ml 208 cm 280 ml 11.7 ml/hr 30 ml 211 cm 288 ml 12.0 ml/hr 38 ml 213 cm 293 ml 12.2 ml/hr 43 ml 5. Record the volume of Normal Saline (as per final volume on chart above) on the Parenteral Study Supplement Log, for this patient daily. 6. Generate a label and attach to the bag. Version: 3-Jul-09 (EU) Replaces version: 6-Dec-07 (EU)

Appendix G Parenteral Study Supplement Study: REDOXS Parenteral Component For Clinical trial Use Only Enrollment #: Directions: Infuse at 10 ml/hr Patient CR#/ID#: Storage: keep between 15-25 Patient Name: Expiry: Physician: Date: 20

Appendix H. Height and Dose of Dipeptiven Ht (ft in) Ht (cms) Dipeptiven Se N/S Total mls mls mls mls 6 0 183 208 10 32 250 6 1 185 212 10 28 250 6 2 188 220 10 20 250 6 3 191 228 10 12 250 6 4 193 233 10 7 250 6 5 196 240 10 --- 250 6 6 198 245 10 --- 255 6 7 201 253 10 --- 263 6 8 203 258 10 --- 268 6 9 206 265 10 --- 275 6 10 208 270 10 --- 280 6 11 211 278 10 --- 288 7 0 213 283 10 --- 293 21